Examples Of Ethical Challenges: Pharmacare

PharmaCARE’s Ethical Challenges
In determining the degree to which a corporation or an individual is ethical, one must first define what it means for such an entity to be ethical. Some might argue that simply conducting business within established public law is all that it takes to be ethical, while other may argue that any behavior that causes harm to another individual or corporation would be unethical. For most, however, the definition of ethical behavior actually falls somewhere in between the two aforementioned extremes. While finding two people that entirely agree on the definition of ethical behavior is challenging, finding agreement on that which is truly unethical is often quite a bit easier. PharmaCARE’s involvement in the development, production, marketing, and distribution of AD23 is precisely such an example of unethical behavior related to the company’s adherence to government regulations, product safety, marketing and advertising, intellectual property rights, and an overall approach to the conduct of its business in a manner that suggests a wonton disregard to the ideal of fair play (Amico). PharmaCARE’s Primary Ethical Challenges
When judging the degree to which PharmaCARE is an ethical company, a review of their
That said, demonstrating PharmaCARE infringed on the intellectual property right of the individual who initially reformulated the drug will be somewhat more challenging. This challenge is due to the fact that, the research team responsible for that reformulation was employed by PharmaCARE at the time of it development and within the employment agreement, PharmCARE expressly indicated that all such developments, while under the employ of PharmCARE are the property of PharmaCARE (Brown,